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A 71-year-old man with a history of congestive heart failure
from valvular heart disease who had previously received aortic
and mitral valve replacements was admitted with progressively
worsening mitral perivalvular leak. He was judged to be a
poor operative candidate and underwent percutaneous
closure of the leak utilizing Amplatzer occluder device. Post-
procedure, he was noted to have red urine (Figure 1) and his
creatinine increased from 1.3 to 1.7 mg/100 ml. Enalapril and
furosemide were stopped but the creatinine kept rising until
it reached 2.8 mg/100 ml on the sixth day after valve closure.
Hemoglobin had also dropped from 13.3 g/100 ml on
admission to 10 g/100 ml. Urine analysis showed 2þ protein,
3þ heme, 23 WBC/HPF, 7 RBC/HPF, and 6–15 granular
casts/HPF. A renal ultrasonogram was normal.
What is the cause of his renal failure?
How will you confirm the diagnosis?
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Figure 1 | Red urine.
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The Diagnosis | Hemoglobinuria
Lactate dehydrogenase level was 3347 U/l. Liver function tests
showed an elevated aspartate aminotransferase level of 157 U/l
and an indirect bilirubin of 3.6 mg/100 ml. Schistocytes were
noted on the peripheral smear. Patient was started on
intravenous dextrose 5% with 150 meq. bicarbonate/l drip
at 75 ml/h. He also received darboepoietin, iron sulfate,
folic acid, and N-acetyl cysteine. Hemogloblin dropped to
7.7 g/100 ml and he required red blood cells transfusions.
Creatinine increased further to 3.9 mg/100 ml, and there
was persistent hemoglobinuria. A transesophageal echo was
performed showing moderate, possibly severe mitral regur-
gitation with the flow going between the amplatzer device
and the sewing ring of the bioprosthetic valve, resulting in
abnormal rocking of the prosthesis. Patient declined open
mitral valve replacement and was transferred back to his
referring hospital.
We describe a case of renal failure caused by intravascular
hemolysis after percutaneous closure of mitral perivalvular
leak with Amplatzer device. Intravascular hemolysis second-
ary to mechanical and bioprosthetic valves and patent ductus
arteriosus closure devices have been well described in the
literature. Distinct patterns of regurgitant flow associated
with high shear stress were thought to cause hemolysis with
intracardiac devices, whereas the presence of residual ductal
flow was thought to cause hemolysis after percutaneous
closure of patent ductus arteriosus especially with Amplatzer
occluders. Recently, hemolytic anemia has been reported
subsequent to percutaneous closure of traumatic ventricular
septal defect using Amplatzer device, which required multiple
blood transfusions and finally surgical removal of the device.1
A review of 14 procedures performed between 2001 and
2004 on percutaneous closure of prosthetic paravalvular leaks
involving both mitral and aortic valves showed that two
patients had residual leaks and persistent anemia requiring
transfusions at 1-year follow-up.2 A more recent study
involving 11 patients with perivalvular leaks who underwent
percutaneous closure using the Amplatzer occluder resulted
in worsening hemolysis in four patients, improvement in
four, and no change in two patients, concluding that the
Amplatzer occluder should be reserved for poor surgical
candidates.3 None of the patients in these two studies
developed renal failure.
Even though kidney dysfunction has been rarely described
following percutaneous closure devices, we believe that
hemolysis should be considered as part of the differential in
any patient who presents with renal failure after prosthetic
device placement.
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